Flora Long-Van

Quebec, QC G1V4G2, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Corrigendum to "First versus second-generation molecular profiling tests: How both can guide decision-making in early-stage hormone-receptor positive breast cancers?" [Cancer Treat. Rev. 135 (2025) 102909].

Corrigendum to "First versus second-generation molecular profiling tests: How both can guide decision-making in early-stage hormone-receptor positive breast cancers?" [Cancer Treat. Rev. 135 (2025) 102909].

Journal: Cancer treatment reviews

Published: January 28, 2026

Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negative breast cancer.

Fibrillarin-mediated ribosomal RNA maturation is a novel therapeutic vulnerability in triple-negative breast cancer.

Journal: Breast cancer research : BCR

Published: April 22, 2025

First versus second-generation molecular profiling tests: How both can guide decision-making in early-stage hormone-receptor positive breast cancers?

First versus second-generation molecular profiling tests: How both can guide decision-making in early-stage hormone-receptor positive breast cancers?

Journal: Cancer treatment reviews

Published: January 03, 2025

Targeting sphingolipid metabolism in chronic lymphocytic leukemia.

Targeting sphingolipid metabolism in chronic lymphocytic leukemia.

Journal: Clinical and experimental medicine

Published: May 14, 2024

Non-canonical transcriptional regulation of the poor prognostic factor UGT2B17 in chronic lymphocytic leukemic and normal B cells.

Non-canonical transcriptional regulation of the poor prognostic factor UGT2B17 in chronic lymphocytic leukemic and normal B cells.

Journal: BMC cancer

Published: August 22, 2023

Untargeted metabolomics identifies metabolic dysregulation of sphingolipids associated with aggressive chronic lymphocytic leukaemia and poor survival.

Untargeted metabolomics identifies metabolic dysregulation of sphingolipids associated with aggressive chronic lymphocytic leukaemia and poor survival.

Journal: Clinical and translational medicine

Published: May 11, 2023

A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome.

A Non-Canonical Role for the Glycosyltransferase Enzyme UGT2B17 as a Novel Constituent of the B Cell Receptor Signalosome.

Journal: Cells

Published: March 28, 2023

A liquid chromatography-mass spectrometry assay for the quantification of nucleotide sugars in human plasma and urine specimens and its clinical application.

A liquid chromatography-mass spectrometry assay for the quantification of nucleotide sugars in human plasma and urine specimens and its clinical application.

Journal: Journal of chromatography. A

Published: April 26, 2022

Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancer.

Extensive metabolic consequences of human glycosyltransferase gene knockouts in prostate cancer.

Journal: British journal of cancer

Published: January 24, 2022

Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer.

Low level of Fibrillarin, a ribosome biogenesis factor, is a new independent marker of poor outcome in breast cancer.

Journal: BMC cancer

Published: June 01, 2021

Ribosomal RNA 2'O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer.

Ribosomal RNA 2'O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer.

Journal: NAR cancer

Published: July 08, 2020

Iron and hepcidin mediate human colorectal cancer cell growth.

Iron and hepcidin mediate human colorectal cancer cell growth.

Journal: Chemico-biological interactions

Published: October 31, 2019

Showing 1-12 of 14

Last Updated: 09/26/2026